Ceftriaxone resistant Shigella Flexneri, an emerging problem.
Indian J Med Sci
;
2010 Dec; 64(12) 556-559
Article
in English
| IMSEAR
| ID: sea-145579
ABSTRACT
Shigellosis is a disease of public health importance in developing countries. It may cause self-limited diarrhea to severe dysentery. Emergence of multi drug resistant (MDR) strains is a growing concern globally. Ceftriaxone and ciprofloxacin are the drugs of choice for MDR cases. Here, we report a case of MDR Shigella flexneri from an immunocompromised patient. The strain was resistant to ceftriaxone [minimum inhibitory concentration (MIC) ≥ 64 μg/ml], limiting the treatment option. Simultaneously, the strain was also found to be resistant to ciprofloxacin (MIC ≥ 4 μg/ml). However, it was susceptible to ceftazidime (MIC 4 μg/ml). This is the first case of ceftriaxone resistant Shigella spp. reported from our hospital.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Shigella flexneri
/
Ceftriaxone
/
Female
/
Humans
/
Microbial Sensitivity Tests
/
Ceftazidime
/
Immunocompromised Host
/
Drug Resistance, Bacterial
/
Dysentery, Bacillary
/
Middle Aged
Language:
English
Journal:
Indian J Med Sci
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS